BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9092358)

  • 1. [Cytokines and lupus].
    Emilie D; Llorente L; Galanaud P
    Ann Med Interne (Paris); 1996; 147(7):480-4. PubMed ID: 9092358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E2-mediated dysregulation of proinflammatory cytokine production in pristane-induced lupus mice.
    Chae BS; Shin TY; Kim DK; Eun JS; Leem JY; Yang JH
    Arch Pharm Res; 2008 Apr; 31(4):503-10. PubMed ID: 18449509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant cytokine expression and autocrine regulation characterize macrophages from young MRL+/+ and NZB/W F1 lupus-prone mice.
    Alleva DG; Kaser SB; Beller DI
    J Immunol; 1997 Dec; 159(11):5610-9. PubMed ID: 9548504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interleukin 10 in disseminated lupus erythematosus].
    Emilie D
    J Soc Biol; 2002; 196(1):19-21. PubMed ID: 12134628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of interleukin-6 and interleukin-10 in B cell hyperactivity in systemic lupus erythematosus.
    Cross JT; Benton HP
    Inflamm Res; 1999 May; 48(5):255-61. PubMed ID: 10391113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine manipulation by methotrexate treatment in murine experimental systemic lupus erythematosus.
    Dayan M; Segal R; Mozes E
    J Rheumatol; 1997 Jun; 24(6):1075-82. PubMed ID: 9195512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus.
    Amel-Kashipaz MR; Huggins ML; Lanyon P; Robins A; Todd I; Powell RJ
    J Autoimmun; 2001 Sep; 17(2):155-63. PubMed ID: 11591124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P; Langnickel D; Riemekasten G
    Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [B-cell anomalies in systemic lupus erythematosus].
    Tron F; Jacquot S; Gilbert D
    Ann Med Interne (Paris); 2002 Dec; 153(8):503-12. PubMed ID: 12610424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic defects in macrophage IL-12 production associated with immune dysfunction in the MRL/++ and New Zealand Black/White F1 lupus-prone mice and the Leishmania major-susceptible BALB/c strain.
    Alleva DG; Kaser SB; Beller DI
    J Immunol; 1998 Dec; 161(12):6878-84. PubMed ID: 9862720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus.
    Ohtsuka K; Gray JD; Stimmler MM; Toro B; Horwitz DA
    J Immunol; 1998 Mar; 160(5):2539-45. PubMed ID: 9498800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasculitis in the Palmerston North mouse model of lupus: phenotype and cytokine production profile of infiltrating cells.
    Luzina IG; Knitzer RH; Atamas SP; Gause WC; Papadimitriou JC; Sztein MB; Storrer CE; Handwerger BS
    Arthritis Rheum; 1999 Mar; 42(3):561-8. PubMed ID: 10088780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-ribosomal P protein antibody in human systemic lupus erythematosus up-regulates the expression of proinflammatory cytokines by human peripheral blood monocytes.
    Nagai T; Arinuma Y; Yanagida T; Yamamoto K; Hirohata S
    Arthritis Rheum; 2005 Mar; 52(3):847-55. PubMed ID: 15751081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interleukin 10: a key cytokine in disseminated lupus erythematosus].
    Emilie D; Couderc J; Llorente L; Galanaud P
    Pathol Biol (Paris); 1998 Oct; 46(8):583-5. PubMed ID: 9871928
    [No Abstract]   [Full Text] [Related]  

  • 15. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus.
    Horwitz DA; Gray JD; Behrendsen SC; Kubin M; Rengaraju M; Ohtsuka K; Trinchieri G
    Arthritis Rheum; 1998 May; 41(5):838-44. PubMed ID: 9588735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A subset of CD4+ T cells expressing early activation antigen CD69 in murine lupus: possible abnormal regulatory role for cytokine imbalance.
    Ishikawa S; Akakura S; Abe M; Terashima K; Chijiiwa K; Nishimura H; Hirose S; Shirai T
    J Immunol; 1998 Aug; 161(3):1267-73. PubMed ID: 9686587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus.
    Decker P; Kötter I; Klein R; Berner B; Rammensee HG
    Rheumatology (Oxford); 2006 Sep; 45(9):1087-95. PubMed ID: 16527880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Kanda N; Tsuchida T; Tamaki K
    Arthritis Rheum; 1999 Feb; 42(2):328-37. PubMed ID: 10025928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoreactive T cell clones from patients with systemic lupus erythematosus support polyclonal autoantibody production.
    Takeno M; Nagafuchi H; Kaneko S; Wakisaka S; Oneda K; Takeba Y; Yamashita N; Suzuki N; Kaneoka H; Sakane T
    J Immunol; 1997 Apr; 158(7):3529-38. PubMed ID: 9120315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mycotoxins citrinin and gliotoxin differentially affect production of the pro-inflammatory cytokines tumour necrosis factor-alpha and interleukin-6, and the anti-inflammatory cytokine interleukin-10.
    Johannessen LN; Nilsen AM; Løvik M
    Clin Exp Allergy; 2005 Jun; 35(6):782-9. PubMed ID: 15969670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.